Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

Abstract Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. The serum level of soluble CD163 (sCD163), a macrophage activation marker, is associated with liver tissue changes; however, its prognostic value is unknown. Here, we determined the utilit...

Full description

Bibliographic Details
Main Authors: Miwa Kawanaka, Ken Nishino, Mayuko Kawada, Katsunori Ishii, Tomohiro Tanikawa, Ryo Katsumata, Noriyo Urata, Jun Nakamura, Mitsuhiko Suehiro, Ken Haruma, Hirofumi Kawamoto
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Gastroenterology
Subjects:
Nonalcoholic fatty liver disease
Soluble CD163
Hepatocellular carcinoma
Cirrhosis
Prognosis
Online Access:https://doi.org/10.1186/s12876-023-02786-4

Internet

https://doi.org/10.1186/s12876-023-02786-4

Similar Items